Amager Hospital is located in Denmark on the island of Amager in Copenhagen. It was founded on April 1, 1997, with the merger of Skt. Elisabeth Hospital and Sundby Hospital. Administratively, Amager Hospital is maintained by Region Hovedstaden.

During the past decade, Amager Hospital conducted 13 clinical trials. In the 10-year time frame, 13 clinical trials started and 3 clinical trials were completed, i.e. on average, 23.1% percent of trials that started reached the finish line to date. In the past 5 years, 9 clinical trials started and 1 clinical trials were completed. i.e. 11.1% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Amager Hospital" #1 sponsor was "Amgen" with 3 trials, followed by "Amager Hospital" with 2 trials sponsored, "Herlev and Gentofte Hospital" with 2 trials sponsored, "Pfizer" with 2 trials sponsored and "Bayer" with 2 trials sponsored. Other sponsors include 5 different institutions and companies that sponsored additional 15 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Amager Hospital" #1 collaborator was "Danish Heart Foundation" with 3 trials as a collaborator, "University of Copenhagen" with 2 trials as a collaborator, "Abbott" with 1 trials as a collaborator, "Acarix" with 1 trials as a collaborator and "Bispebjerg Hospital" with 1 trials as a collaborator. Other collaborators include 13 different institutions and companies that were collaborators in the rest 23 trials.

According to Clinical.Site data, the most researched conditions in "Amager Hospital" are "Atherosclerotic Cardiovascular Disease" (3 trials), "Atrial Fibrillation" (3 trials), "Cardiovascular Disease" (3 trials), "Dyslipidemia" (2 trials) and "Hypercholesterolemia" (2 trials). Many other conditions were trialed in "Amager Hospital" in a lesser frequency.

Most popular intervention types in "Amager Hospital" are "Drug" (13 trials), "Other" (3 trials), "Behavioral" (2 trials) and "Device" (2 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (4 trials), "Apixaban Oral Tablet" (2 trials), "Dabigatran Etexilate Oral Capsule" (2 trials), "Edoxaban Oral Tablet" (2 trials) and "Evolocumab" (2 trials). Other intervention names were less common.

The vast majority of trials in "Amager Hospital" are 19 trials for "All" genders and 1 trials for "Male" genders.

Currently, there are NaN active trials in "Amager Hospital". 1 are not yet recruiting, 6 are recruiting, 2 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 8 completed trials in Amager Hospital, undefined suspended trials, and 3 terminated clinical trials to date.

Out of the total trials that were conducted in Amager Hospital, 0 "Phase 1" clinical trials were conducted, 2 "Phase 2" clinical trials and 8 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 3 trials, and there were also 6 trials that are defined as “Not Applicable".